iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Shilpa Medicare Secures EU GMP Certification for Hyderabad Facility

23 Dec 2024 , 01:30 PM

Shilpa Medicare Ltd has received Good Manufacturing Practice (GMP) certification from a European Union (EU) agency for its Unit 7 facility in Telangana.

The certification followed a successful inspection by the European Medicines Agency, Austria, held from September 24 to September 26 at the Nacharam, Hyderabad facility. Unit 7 has Analytical Services Division, (QC), and the Bio-Analytical
Department that play the major role in testing of drug substances, raw materials, packaging materials, and finished products. This is the first inspection by any European agency for the QC laboratory of Unit 7. For the company, this will be a significant milestone.

In the National Stock Exchange, shares of Shilpa Medicare Ltd is currently trading at ₹772.40 at 1:20 pm on December 23, 2024. This is a 5% dip than the previous close.

The facility also carries out analytical method validations, method transfers, and other special analytical studies. These samples, coming to this laboratory, are meant for the final release to key markets in the United States, European Union, and so on.

Both the Analytical Services and Bio-Analytical Laboratories at Unit 7 have already received approval from the USFDA.
Furthermore, the Bio-Analytical Laboratory is certified by EMA Europe, establishing Shilpa Medicare as compliant with international standards. This achievement further enhances the capabilities of the company in satisfying global pharmaceutical regulatory requirements and expands its reach in the US and EU markets.

Related Tags

  • EU GMP Certification
  • Shilpa Medicare
  • Shilpa Medicare Ltd
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Most Read News

Top Stocks for Today - 2nd April 2025
2 Apr 2025|07:31 AM
Dabur Faces ₹110.33 Crore Tax Demand
1 Apr 2025|11:10 PM
Tata Motors Sees 3% Rise in PV Sales
1 Apr 2025|10:56 PM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.